 ELOX | Eloxx Pharmaceuticals, Inc. Company profile
Company profileEloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates (designed to be eukaryotic ribosomal selective glycosides) that are designed to treat rare and ultra-rare premature stop codon diseases.
Address950 Winter Street | NotesJump to (Finance sites)         ResearchInvestor pageinvestors.eloxxpharma.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Their Official Profiles  Other stocks            Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended Books Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology. |